Universitätsklinikum Heidelberg: Posterpräsentationen
Frontiers | Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
Restoration of SHIP-1 activity in human leukemic cells modifies NF-κB activation pathway and cellular survival upon oxidative stress | Oncogene
p-RELA/NFκB p65 Antibody (27.Ser 536) | SCBT - Santa Cruz Biotechnology
p-RELA/NFκB p65 Antibody (27.Ser 536) | SCBT - Santa Cruz Biotechnology
Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells - ScienceDirect
IL-6-independent expression of Mcl-1 in human multiple myeloma | Oncogene
Restoration of SHIP-1 activity in human leukemic cells modifies NF-κB activation pathway and cellular survival upon oxidative stress | Oncogene
p-RELA/NFκB p65 Antibody (27.Ser 536) | SCBT - Santa Cruz Biotechnology
Chronic lymphocytic leukemia - Wikipedia
Protein Delivery and Mimicry | SpringerLink
IFN gamma Monoclonal Antibody (4S.B3), eFluor™ 506 (69-7319-42)
IFN gamma Monoclonal Antibody (4S.B3), Biotin (13-7319-81)
Gold nanoparticles as antiangiogenic and antimetastatic agents - ScienceDirect
DEMA
p-RELA/NFκB p65 Antibody (27.Ser 536) | SCBT - Santa Cruz Biotechnology
Full article: UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
p-RELA/NFκB p65 Antibody (27.Ser 536) | SCBT - Santa Cruz Biotechnology
Cancers | Free Full-Text | Awakening of Dormant Breast Cancer Cells in the Bone Marrow
Restoration of SHIP-1 activity in human leukemic cells modifies NF-κB activation pathway and cellular survival upon oxidative stress | Oncogene
Microbiota in cancer: molecular mechanisms and therapeutic interventions - Chen - 2023 - MedComm - Wiley Online Library
Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells | Cancer Cell International | Full Text
